Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

Mold Control and Detection in Biological Drug Substance Manufacturing Facilities: An Industry Perspective

Anita Bawa, Sofia Asefi, Stephanie Ramsey, Christine Arbesser-Rastburg, Mousumi Paul, Fran Leira, Tracy Landeryou, Bindhu Reddy, Marie Murphy, Barbara Daddis and David Bain
PDA Journal of Pharmaceutical Science and Technology September 2017, 71 (5) 413-420; DOI: https://doi.org/10.5731/pdajpst.2016.007351
Anita Bawa
Director, QC, Bayer, 800 Dwight Way, Berkeley, CA 94710, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sofia Asefi
QC Senior Manager, Bayer, 800 Dwight Way, Berkeley, CA 94710, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Ramsey
Manager Quality Systems, Shire 1 Baxter Way, Westlake Village, CA 91362, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Arbesser-Rastburg
Director, Global Microbiology Shire, Industriestraße 67, 1220, Wien, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mousumi Paul
Associate Director, Biologics Quality Operations, Merck, 770 Sumneytown Pike, West Point, PA 19486, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fran Leira
Global MSAT/QC Head, Lonza La Relva s/n ES - 36400 Porrino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tracy Landeryou
Director QC Microbiology, Pfizer, 1 Burtt Rd, Andover, MA 01810, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bindhu Reddy
QC Supervisor, AstraZeneca / MedImmune 1 Medimmune Way, Gaithersburg, MD 20878, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Murphy
Microbiologist, Biotechnology Operations, Eli Lilly, Hyde House Saint Kevin's 2vrm, 65 Adelaide Rd, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Daddis
Associate Director of Microbiological Control, Bristol-Myers Squibb, Bristol-Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08902
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Bain
Facilitator, BPOG, 5 Westbrook Court, Sharrowvale Rd, Sheffield S11 8YZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 71 no. 5 413-420
DOI 
https://doi.org/10.5731/pdajpst.2016.007351
PubMed 
28624776

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online October 11, 2017.

Article Versions

  • previous version (June 16, 2017 - 18:59).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© PDA, Inc. 2017

Author Information

Cited By...

  • 2 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Case study on the environmental monitoring for biological manufacturing using Time-lapse Shadow Image Analysis
    Shoji Narutaki, Ineui Lee, Yasuhito Sugawara, Kahei Akada, Akihiko Kondo
    Biologicals 2020 66
  • Validation of the Growth Direct System for Microbial Environmental Monitoring and Define Optimal Incubation Conditions
    Courtney Russell, Niloufar Parsaei, David L Jones
    EJPPS EUROPEAN JOURNAL OF PARENTERAL AND PHARMACEUTICAL SCIENCES 2020
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 71 (5)
PDA Journal of Pharmaceutical Science and Technology
Vol. 71, Issue 5
September/October 2017
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mold Control and Detection in Biological Drug Substance Manufacturing Facilities: An Industry Perspective
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Mold Control and Detection in Biological Drug Substance Manufacturing Facilities: An Industry Perspective
Anita Bawa, Sofia Asefi, Stephanie Ramsey, Christine Arbesser-Rastburg, Mousumi Paul, Fran Leira, Tracy Landeryou, Bindhu Reddy, Marie Murphy, Barbara Daddis, David Bain
PDA Journal of Pharmaceutical Science and Technology Sep 2017, 71 (5) 413-420; DOI: 10.5731/pdajpst.2016.007351

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Mold Control and Detection in Biological Drug Substance Manufacturing Facilities: An Industry Perspective
Anita Bawa, Sofia Asefi, Stephanie Ramsey, Christine Arbesser-Rastburg, Mousumi Paul, Fran Leira, Tracy Landeryou, Bindhu Reddy, Marie Murphy, Barbara Daddis, David Bain
PDA Journal of Pharmaceutical Science and Technology Sep 2017, 71 (5) 413-420; DOI: 10.5731/pdajpst.2016.007351
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Scope
    • Background
    • Mold Monitoring in Biologics DS Facilities
    • Responding to Mold Isolation Events
    • Mold Prevention Practices
    • Conclusion
    • Conflict of Interest Declaration
    • Relevant Literature
    • Acknowledgements
    • Reference
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Challenges and Solutions to Manufacturing of Low-Viscosity, Ultra-High Concentration IgG1 Drug Products: From Late Downstream Process to Final Fill Finish Processing
  • Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
  • Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
Show more Commentary

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire